<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2017-10-25" version="190">
<accession>Q92794</accession>
<accession>Q76L81</accession>
<name>KAT6A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Histone acetyltransferase KAT6A</fullName>
<ecNumber evidence="19 20">2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3</fullName>
<shortName>MYST-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Monocytic leukemia zinc finger protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Runt-related transcription factor-binding protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger protein 220</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">KAT6A</name>
<name type="synonym">MOZ</name>
<name type="synonym">MYST3</name>
<name type="synonym">RUNXBP2</name>
<name type="synonym">ZNF220</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Nat. Genet." volume="14" first="33" last="41">
<title>The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.</title>
<authorList>
<person name="Borrow J."/>
<person name="Stanton V.P. Jr."/>
<person name="Andresen J.M."/>
<person name="Becher R."/>
<person name="Behm F.G."/>
<person name="Chaganti R.S.K."/>
<person name="Civin C.I."/>
<person name="Disteche C."/>
<person name="Dube I."/>
<person name="Frischauf A.M."/>
<person name="Horsman D."/>
<person name="Mitelman F."/>
<person name="Volinia S."/>
<person name="Watmore A.E."/>
<person name="Housman D.E."/>
</authorList>
<dbReference type="PubMed" id="8782817"/>
<dbReference type="DOI" id="10.1038/ng0996-33"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH CREBBP</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2002-04" db="EMBL/GenBank/DDBJ databases">
<title>MOZ is fused to a novel Polycomb group gene in a therapy-related myelodysplastic syndrome with t(2;8)(p23;p11.2).</title>
<authorList>
<person name="Hosoda F."/>
<person name="Kitabayashi I."/>
<person name="Kakazu N."/>
<person name="Fukushima M."/>
<person name="Aikawa Y."/>
<person name="Abe T."/>
<person name="Hibi S."/>
<person name="Yagi T."/>
<person name="Ohki M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-813</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH ASXL2</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="Blood" volume="91" first="3127" last="3133">
<title>A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.</title>
<authorList>
<person name="Carapeti M."/>
<person name="Aguiar R.C.T."/>
<person name="Goldman J.M."/>
<person name="Cross N.C.P."/>
</authorList>
<dbReference type="PubMed" id="9558366"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1089-1117</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCOA2</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Genes Chromosomes Cancer" volume="28" first="138" last="144">
<title>MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).</title>
<authorList>
<person name="Chaffanet M."/>
<person name="Gressin L."/>
<person name="Preudhomme C."/>
<person name="Soenen-Cornu V."/>
<person name="Birnbaum D."/>
<person name="Pebusque M.-J."/>
</authorList>
<dbReference type="PubMed" id="10824998"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-2264(200006)28:2&lt;138::AID-GCC2>3.0.CO;2-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1111-1128</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH EP300</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="7184" last="7196">
<title>Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.</title>
<authorList>
<person name="Kitabayashi I."/>
<person name="Aikawa Y."/>
<person name="Nguyen L.A."/>
<person name="Yokoyama A."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="11742995"/>
<dbReference type="DOI" id="10.1093/emboj/20.24.7184"/>
</citation>
<scope>INTERACTION WITH RUNX1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACETYLATION</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH CREBBP</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="404" last="409">
<title>The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.</title>
<authorList>
<person name="Champagne N."/>
<person name="Pelletier N."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="11313971"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204114"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="2729" last="2740">
<title>MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.</title>
<authorList>
<person name="Pelletier N."/>
<person name="Champagne N."/>
<person name="Stifani S."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="11965546"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205367"/>
</citation>
<scope>INTERACTION WITH RUNX2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Cancer Cell" volume="3" first="259" last="271">
<title>MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.</title>
<authorList>
<person name="Deguchi K."/>
<person name="Ayton P.M."/>
<person name="Carapeti M."/>
<person name="Kutok J.L."/>
<person name="Snyder C.S."/>
<person name="Williams I.R."/>
<person name="Cross N.C.P."/>
<person name="Glass C.K."/>
<person name="Cleary M.L."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="12676584"/>
<dbReference type="DOI" id="10.1016/S1535-6108(03)00051-5"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCOA2</scope>
<scope>MUTAGENESIS OF CYS-543 AND GLY-657</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nucleic Acids Res." volume="31" first="2735" last="2744">
<title>Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.</title>
<authorList>
<person name="Bristow C.A.P."/>
<person name="Shore P."/>
</authorList>
<dbReference type="PubMed" id="12771199"/>
<dbReference type="DOI" id="10.1093/nar/gkg401"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="988" last="1002">
<title>MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.</title>
<authorList>
<person name="Kindle K.B."/>
<person name="Troke P.J.F."/>
<person name="Collins H.M."/>
<person name="Matsuda S."/>
<person name="Bossi D."/>
<person name="Bellodi C."/>
<person name="Kalkhoven E."/>
<person name="Salomoni P."/>
<person name="Pelicci P.G."/>
<person name="Minucci S."/>
<person name="Heery D.M."/>
</authorList>
<dbReference type="PubMed" id="15657427"/>
<dbReference type="DOI" id="10.1128/MCB.25.3.988-1002.2005"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCOA2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="51" last="64">
<title>ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.</title>
<authorList>
<person name="Doyon Y."/>
<person name="Cayrou C."/>
<person name="Ullah M."/>
<person name="Landry A.-J."/>
<person name="Cote V."/>
<person name="Selleck W."/>
<person name="Lane W.S."/>
<person name="Tan S."/>
<person name="Yang X.-J."/>
<person name="Cote J."/>
</authorList>
<dbReference type="PubMed" id="16387653"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.12.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE MOZ/MORF COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="6828" last="6843">
<title>Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.</title>
<authorList>
<person name="Ullah M."/>
<person name="Pelletier N."/>
<person name="Xiao L."/>
<person name="Zhao S.P."/>
<person name="Wang K."/>
<person name="Degerny C."/>
<person name="Tahmasebi S."/>
<person name="Cayrou C."/>
<person name="Doyon Y."/>
<person name="Goh S.-L."/>
<person name="Champagne N."/>
<person name="Cote J."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="18794358"/>
<dbReference type="DOI" id="10.1128/MCB.01297-08"/>
</citation>
<scope>IDENTIFICATION IN THE MOZ/MORF COMPLEX</scope>
<scope>INTERACTION WITH BRPF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-350; LYS-355 AND LYS-1007</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473 AND SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420; SER-473; SER-812; SER-941; SER-954; SER-974; SER-1089; SER-1090 AND SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="3895" last="3900">
<title>MOZ increases p53 acetylation and premature senescence through its complex formation with PML.</title>
<authorList>
<person name="Rokudai S."/>
<person name="Laptenko O."/>
<person name="Arnal S.M."/>
<person name="Taya Y."/>
<person name="Kitabayashi I."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="23431171"/>
<dbReference type="DOI" id="10.1073/pnas.1300490110"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML AND TP53</scope>
<scope>PHOSPHORYLATION AT THR-369</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="498" last="506">
<title>De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.</title>
<authorList>
<consortium name="UCLA Clinical Genomics Center"/>
<person name="Arboleda V.A."/>
<person name="Lee H."/>
<person name="Dorrani N."/>
<person name="Zadeh N."/>
<person name="Willis M."/>
<person name="Macmurdo C.F."/>
<person name="Manning M.A."/>
<person name="Kwan A."/>
<person name="Hudgins L."/>
<person name="Barthelemy F."/>
<person name="Miceli M.C."/>
<person name="Quintero-Rivera F."/>
<person name="Kantarci S."/>
<person name="Strom S.P."/>
<person name="Deignan J.L."/>
<person name="Grody W.W."/>
<person name="Vilain E."/>
<person name="Nelson S.F."/>
</authorList>
<dbReference type="PubMed" id="25728775"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.01.017"/>
</citation>
<scope>INVOLVEMENT IN MRD32</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="507" last="513">
<title>Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.</title>
<authorList>
<person name="Tham E."/>
<person name="Lindstrand A."/>
<person name="Santani A."/>
<person name="Malmgren H."/>
<person name="Nesbitt A."/>
<person name="Dubbs H.A."/>
<person name="Zackai E.H."/>
<person name="Parker M.J."/>
<person name="Millan F."/>
<person name="Rosenbaum K."/>
<person name="Wilson G.N."/>
<person name="Nordgren A."/>
</authorList>
<dbReference type="PubMed" id="25728777"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.01.016"/>
</citation>
<scope>INVOLVEMENT IN MRD32</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-834 AND LYS-1342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="submission" date="2002-06" db="PDB data bank">
<title>Solution structure of a CCCCCHC zinc finger from MOZ.</title>
<authorList>
<person name="Kwan A.H.Y."/>
<person name="Gell D.A."/>
<person name="Liew C.K."/>
<person name="Mackay J.P."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 531-563</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="36603" last="36613">
<title>The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting.</title>
<authorList>
<person name="Holbert M.A."/>
<person name="Sikorski T."/>
<person name="Carten J."/>
<person name="Snowflack D."/>
<person name="Hodawadekar S."/>
<person name="Marmorstein R."/>
</authorList>
<dbReference type="PubMed" id="17925393"/>
<dbReference type="DOI" id="10.1074/jbc.M705812200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 501-784 IN COMPLEXES WITH ACETYL-COA; HISTONE H3 AND HISTONE H4 AND ZINC IONS</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF LYS-545; ILE-727 AND HIS-732</scope>
</reference>
<reference key="27">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>The crystal structure of human MYST histone acetyltransferase 3 in complex with acetylcoenzyme A.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 497-780 IN COMPLEX WITH ACETYL-COA</scope>
<scope>ACETYLATION AT LYS-604</scope>
</reference>
<comment type="function">
<text evidence="20 21 23 24 25 27">Histone acetyltransferase that acetylates lysine residues in histone H3 and histone H4 (in vitro). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. May act as a transcriptional coactivator for RUNX1 and RUNX2. Acetylates p53/TP53 at 'Lys-120' and 'Lys-382' and controls its transcriptional activity via association with PML.</text>
</comment>
<comment type="catalytic activity">
<text evidence="19 20 25">Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine.</text>
</comment>
<comment type="subunit">
<text evidence="20 21 24 26 27 31">Component of the MOZ/MORF complex composed at least of ING5, KAT6A, KAT6B, MEAF6 and one of BRPF1, BRD1/BRPF2 and BRPF3. Interacts with RUNX1; phosphorylation of RUNX1 enhances the interaction. Interacts with RUNX2. Interacts with p53/TP53. Interacts with PML (isoform PML-4) and this interaction positively regulates its acetylation activity towards p53/TP53.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948013"/>
<interactant intactId="EBI-2638616">
<id>Q03164</id>
<label>KMT2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948013"/>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Recruited into PML body after DNA damage.</text>
</comment>
<comment type="domain">
<text evidence="19">The N-terminus is involved in transcriptional activation while the C-terminus is involved in transcriptional repression.</text>
</comment>
<comment type="PTM">
<text evidence="14 31">Autoacetylation at Lys-604 is required for proper function (By similarity). Autoacetylated.</text>
</comment>
<comment type="PTM">
<text evidence="20 27">Phosphorylation at Thr-369 by PKB/AKT1 inhibits its interaction with PML and negatively regulates its acetylation activity towards p53/TP53.</text>
</comment>
<comment type="disease">
<text evidence="18 20 22 30">Chromosomal aberrations involving KAT6A may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with CREBBP (PubMed:8782817). Translocation t(8;22)(p11;q13) with EP300 (PubMed:10824998). KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription (PubMed:11742995). Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation (PubMed:12676584).</text>
</comment>
<comment type="disease">
<text evidence="32">A chromosomal aberration involving KAT6A is a cause of therapy-related myelodysplastic syndrome. Translocation t(2;8)(p23;p11.2) with ASXL2 generates a KAT6A-ASXL2 fusion protein.</text>
</comment>
<comment type="disease" evidence="28 29">
<disease id="DI-04351">
<name>Mental retardation, autosomal dominant 32</name>
<acronym>MRD32</acronym>
<description>A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD32 patients manifest intellectual disability, dysmorphic facial features, delayed psychomotor development, and lack of speech.</description>
<dbReference type="MIM" id="616268"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="33">Belongs to the MYST (SAS/MOZ) family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MYST3ID25ch8p11.html"/>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="19 20"/>
<dbReference type="EMBL" id="U47742">
<property type="protein sequence ID" value="AAC50662.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC090571">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB084281">
<property type="protein sequence ID" value="BAD00088.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6124.1"/>
<dbReference type="RefSeq" id="NP_006757.2">
<property type="nucleotide sequence ID" value="NM_006766.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869352.1">
<property type="nucleotide sequence ID" value="XM_017013863.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869353.1">
<property type="nucleotide sequence ID" value="XM_017013864.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.491577"/>
<dbReference type="PDB" id="1M36">
<property type="method" value="NMR"/>
<property type="chains" value="A=533-563"/>
</dbReference>
<dbReference type="PDB" id="2LN0">
<property type="method" value="NMR"/>
<property type="chains" value="A=204-313"/>
</dbReference>
<dbReference type="PDB" id="2OZU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=497-780"/>
</dbReference>
<dbReference type="PDB" id="2RC4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=501-784"/>
</dbReference>
<dbReference type="PDB" id="3V43">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.47"/>
<property type="chains" value="A=204-313"/>
</dbReference>
<dbReference type="PDB" id="4LJN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="4LK9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="4LKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.61"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="4LLB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B75">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B76">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B77">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B78">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDBsum" id="1M36"/>
<dbReference type="PDBsum" id="2LN0"/>
<dbReference type="PDBsum" id="2OZU"/>
<dbReference type="PDBsum" id="2RC4"/>
<dbReference type="PDBsum" id="3V43"/>
<dbReference type="PDBsum" id="4LJN"/>
<dbReference type="PDBsum" id="4LK9"/>
<dbReference type="PDBsum" id="4LKA"/>
<dbReference type="PDBsum" id="4LLB"/>
<dbReference type="PDBsum" id="5B75"/>
<dbReference type="PDBsum" id="5B76"/>
<dbReference type="PDBsum" id="5B77"/>
<dbReference type="PDBsum" id="5B78"/>
<dbReference type="ProteinModelPortal" id="Q92794"/>
<dbReference type="SMR" id="Q92794"/>
<dbReference type="BioGrid" id="113703">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="CORUM" id="Q92794"/>
<dbReference type="IntAct" id="Q92794">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000265713"/>
<dbReference type="ChEMBL" id="CHEMBL3774298"/>
<dbReference type="iPTMnet" id="Q92794"/>
<dbReference type="PhosphoSitePlus" id="Q92794"/>
<dbReference type="BioMuta" id="KAT6A"/>
<dbReference type="DMDM" id="215274095"/>
<dbReference type="EPD" id="Q92794"/>
<dbReference type="MaxQB" id="Q92794"/>
<dbReference type="PaxDb" id="Q92794"/>
<dbReference type="PeptideAtlas" id="Q92794"/>
<dbReference type="PRIDE" id="Q92794"/>
<dbReference type="DNASU" id="7994"/>
<dbReference type="Ensembl" id="ENST00000265713">
<property type="protein sequence ID" value="ENSP00000265713"/>
<property type="gene ID" value="ENSG00000083168"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396930">
<property type="protein sequence ID" value="ENSP00000380136"/>
<property type="gene ID" value="ENSG00000083168"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406337">
<property type="protein sequence ID" value="ENSP00000385888"/>
<property type="gene ID" value="ENSG00000083168"/>
</dbReference>
<dbReference type="GeneID" id="7994"/>
<dbReference type="KEGG" id="hsa:7994"/>
<dbReference type="UCSC" id="uc003xon.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7994"/>
<dbReference type="DisGeNET" id="7994"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000083168.9"/>
<dbReference type="GeneCards" id="KAT6A"/>
<dbReference type="HGNC" id="HGNC:13013">
<property type="gene designation" value="KAT6A"/>
</dbReference>
<dbReference type="HPA" id="CAB017023"/>
<dbReference type="HPA" id="HPA063266"/>
<dbReference type="HPA" id="HPA065052"/>
<dbReference type="MalaCards" id="KAT6A"/>
<dbReference type="MIM" id="601408">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616268">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92794"/>
<dbReference type="OpenTargets" id="ENSG00000083168"/>
<dbReference type="Orphanet" id="370026">
<property type="disease" value="Acute myeloid leukemia with t(8;16)(p11;p13) translocation"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37592"/>
<dbReference type="eggNOG" id="KOG2747">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5027">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074503"/>
<dbReference type="HOGENOM" id="HOG000234365"/>
<dbReference type="HOVERGEN" id="HBG052563"/>
<dbReference type="InParanoid" id="Q92794"/>
<dbReference type="KO" id="K11305"/>
<dbReference type="OMA" id="CDPPLTR"/>
<dbReference type="OrthoDB" id="EOG091G00D2"/>
<dbReference type="PhylomeDB" id="Q92794"/>
<dbReference type="TreeFam" id="TF106483"/>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804758">
<property type="pathway name" value="Regulation of TP53 Activity through Acetylation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q92794"/>
<dbReference type="ChiTaRS" id="KAT6A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92794"/>
<dbReference type="GeneWiki" id="MYST3"/>
<dbReference type="GenomeRNAi" id="7994"/>
<dbReference type="PRO" id="PR:Q92794"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000083168"/>
<dbReference type="CleanEx" id="HS_MYST3"/>
<dbReference type="ExpressionAtlas" id="Q92794">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92794">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070776">
<property type="term" value="C:MOZ/MORF histone acetyltransferase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000786">
<property type="term" value="C:nucleosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016407">
<property type="term" value="F:acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090398">
<property type="term" value="P:cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006323">
<property type="term" value="P:DNA packaging"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016573">
<property type="term" value="P:histone acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006334">
<property type="term" value="P:nucleosome assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR016181">
<property type="entry name" value="Acyl_CoA_acyltransferase"/>
</dbReference>
<dbReference type="InterPro" id="IPR002717">
<property type="entry name" value="HAT_MYST-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR005818">
<property type="entry name" value="Histone_H1/H5_H15"/>
</dbReference>
<dbReference type="InterPro" id="IPR031280">
<property type="entry name" value="KAT6A"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011011">
<property type="entry name" value="Znf_FYVE_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001965">
<property type="entry name" value="Znf_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR019787">
<property type="entry name" value="Znf_PHD-finger"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10615:SF26">
<property type="entry name" value="PTHR10615:SF26"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="Pfam" id="PF01853">
<property type="entry name" value="MOZ_SAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00628">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00526">
<property type="entry name" value="H15"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00249">
<property type="entry name" value="PHD"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55729">
<property type="entry name" value="SSF55729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57903">
<property type="entry name" value="SSF57903"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51504">
<property type="entry name" value="H15"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51726">
<property type="entry name" value="MYST_HAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01359">
<property type="entry name" value="ZF_PHD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50016">
<property type="entry name" value="ZF_PHD_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Histone acetyltransferase KAT6A" id="PRO_0000051572">
<location>
<begin position="1"/>
<end position="2004"/>
</location>
</feature>
<feature type="domain" description="H15" evidence="16">
<location>
<begin position="95"/>
<end position="171"/>
</location>
</feature>
<feature type="domain" description="MYST-type HAT" evidence="17">
<location>
<begin position="504"/>
<end position="778"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 1" evidence="15">
<location>
<begin position="206"/>
<end position="265"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 2" evidence="15">
<location>
<begin position="259"/>
<end position="313"/>
</location>
</feature>
<feature type="zinc finger region" description="C2HC MYST-type" evidence="17">
<location>
<begin position="537"/>
<end position="562"/>
</location>
</feature>
<feature type="region of interest" description="Required for activation of RUNX1-1">
<location>
<begin position="1"/>
<end position="144"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization">
<location>
<begin position="52"/>
<end position="166"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PML" evidence="27">
<location>
<begin position="144"/>
<end position="664"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RUNX1-1">
<location>
<begin position="312"/>
<end position="664"/>
</location>
</feature>
<feature type="region of interest" description="Catalytic">
<location>
<begin position="488"/>
<end position="778"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with BRPF1, required for histone H3 acetyltransferase activity" evidence="26">
<location>
<begin position="507"/>
<end position="810"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="31">
<location>
<begin position="645"/>
<end position="649"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="31">
<location>
<begin position="654"/>
<end position="660"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PML" evidence="27">
<location>
<begin position="1517"/>
<end position="1741"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RUNX1-2">
<location>
<begin position="1517"/>
<end position="1642"/>
</location>
</feature>
<feature type="region of interest" description="Required for activation of RUNX1-2">
<location>
<begin position="1913"/>
<end position="1948"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="371"/>
<end position="379"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="788"/>
<end position="801"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="989"/>
<end position="995"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="1019"/>
<end position="1026"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1069"/>
<end position="1078"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="1147"/>
<end position="1150"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="1221"/>
<end position="1242"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="1267"/>
<end position="1302"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1411"/>
<end position="1414"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="1593"/>
<end position="1597"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln/Pro-rich">
<location>
<begin position="1643"/>
<end position="1704"/>
</location>
</feature>
<feature type="compositionally biased region" description="Met-rich">
<location>
<begin position="1897"/>
<end position="1977"/>
</location>
</feature>
<feature type="active site" description="Proton donor/acceptor" evidence="14">
<location>
<position position="680"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA" evidence="31">
<location>
<position position="684"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-ASXL2">
<location>
<begin position="813"/>
<end position="814"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-EP300 and KAT6A-NCOA2">
<location>
<begin position="1117"/>
<end position="1118"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-CREBBP">
<location>
<begin position="1546"/>
<end position="1547"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKB/AKT1" evidence="27">
<location>
<position position="369"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="420"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="31">
<location>
<position position="604"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="787"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="812"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="815"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="899"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="941"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="954"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="974"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="1007"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1089"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1090"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 10">
<location>
<position position="1113"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="834"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="1342"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3824276." id="VAR_047548">
<original>L</original>
<variation>S</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates HAT activity." evidence="22">
<original>C</original>
<variation>G</variation>
<location>
<position position="543"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced affinity for DNA." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="545"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates HAT activity." evidence="22">
<original>G</original>
<variation>E</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced affinity for DNA." evidence="25">
<original>I</original>
<variation>E</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced affinity for DNA." evidence="25">
<original>H</original>
<variation>D</variation>
<location>
<position position="732"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50662 and 3; BAD00088." ref="1 3" evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="207"/>
<end position="209"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="210"/>
<end position="212"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="239"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="246"/>
<end position="252"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="253"/>
<end position="256"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="293"/>
<end position="295"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="308"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="511"/>
<end position="514"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="517"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="529"/>
<end position="532"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="535"/>
<end position="539"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="541"/>
<end position="543"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="546"/>
<end position="549"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="550"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="566"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="576"/>
<end position="582"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="583"/>
<end position="585"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="587"/>
<end position="598"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="613"/>
<end position="622"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="625"/>
<end position="637"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="642"/>
<end position="649"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="651"/>
<end position="653"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="655"/>
<end position="657"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="658"/>
<end position="672"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="677"/>
<end position="679"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="685"/>
<end position="705"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="713"/>
<end position="720"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="724"/>
<end position="733"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="750"/>
<end position="759"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="771"/>
<end position="773"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OZU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RC4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4LK9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5B76"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5B78"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5TKR9"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BZ21"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9H7Z6"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00146"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00837"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01063"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10824998"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11313971"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11742995"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11965546"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676584"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12771199"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16387653"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17925393"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18794358"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23431171"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25728775"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25728777"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8782817"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source ref="27"/>
</evidence>
<evidence key="32" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="33" type="ECO:0000305"/>
<sequence length="2004" mass="225028" checksum="78357EFAC4698A5F" modified="2008-11-25" version="2">
MVKLANPLYTEWILEAIKKVKKQKQRPSEERICNAVSSSHGLDRKTVLEQLELSVKDGTI
LKVSNKGLNSYKDPDNPGRIALPKPRNHGKLDNKQNVDWNKLIKRAVEGLAESGGSTLKS
IERFLKGQKDVSALFGGSAASGFHQQLRLAIKRAIGHGRLLKDGPLYRLNTKATNVDGKE
SCESLSCLPPVSLLPHEKDKPVAEPIPICSFCLGTKEQNREKKPEELISCADCGNSGHPS
CLKFSPELTVRVKALRWQCIECKTCSSCRDQGKNADNMLFCDSCDRGFHMECCDPPLTRM
PKGMWICQICRPRKKGRKLLQKKAAQIKRRYTNPIGRPKNRLKKQNTVSKGPFSKVRTGP
GRGRKRKITLSSQSASSSSEEGYLERIDGLDFCRDSNVSLKFNKKTKGLIDGLTKFFTPS
PDGRKARGEVVDYSEQYRIRKRGNRKSSTSDWPTDNQDGWDGKQENEERLFGSQEIMTEK
DMELFRDIQEQALQKVGVTGPPDPQVRCPSVIEFGKYEIHTWYSSPYPQEYSRLPKLYLC
EFCLKYMKSRTILQQHMKKCGWFHPPANEIYRKNNISVFEVDGNVSTIYCQNLCLLAKLF
LDHKTLYYDVEPFLFYVLTQNDVKGCHLVGYFSKEKHCQQKYNVSCIMILPQYQRKGYGR
FLIDFSYLLSKREGQAGSPEKPLSDLGRLSYMAYWKSVILECLYHQNDKQISIKKLSKLT
GICPQDITSTLHHLRMLDFRSDQFVIIRREKLIQDHMAKLQLNLRPVDVDPECLRWTPVI
VSNSVVSEEEEEEAEEGENEEPQCQERELEISVGKSVSHENKEQDSYSVESEKKPEVMAP
VSSTRLSKQVLPHDSLPANSQPSRRGRWGRKNRKTQERFGDKDSKLLLEETSSAPQEQYG
ECGEKSEATQEQYTESEEQLVASEEQPSQDGKPDLPKRRLSEGVEPWRGQLKKSPEALKC
RLTEGSERLPRRYSEGDRAVLRGFSESSEEEEEPESPRSSSPPILTKPTLKRKKPFLHRR
RRVRKRKHHNSSVVTETISETTEVLDEPFEDSDSERPMPRLEPTFEIDEEEEEEDENELF
PREYFRRLSSQDVLRCQSSSKRKSKDEEEDEESDDADDTPILKPVSLLRKRDVKNSPLEP
DTSTPLKKKKGWPKGKSRKPIHWKKRPGRKPGFKLSREIMPVSTQACVIEPIVSIPKAGR
KPKIQESEETVEPKEDMPLPEERKEEEEMQAEAEEAEEGEEEDAASSEVPAASPADSSNS
PETETKEPEVEEEEEKPRVSEEQRQSEEEQQELEEPEPEEEEDAAAETAQNDDHDADDED
DGHLESTKKKELEEQPTREDVKEEPGVQESFLDANMQKSREKIKDKEETELDSEEEQPSH
DTSVVSEQMAGSEDDHEEDSHTKEELIELKEEEEIPHSELDLETVQAVQSLTQEESSEHE
GAYQDCEETLAACQTLQSYTQADEDPQMSMVEDCHASEHNSPISSVQSHPSQSVRSVSSP
NVPALESGYTQISPEQGSLSAPSMQNMETSPMMDVPSVSDHSQQVVDSGFSDLGSIESTT
ENYENPSSYDSTMGGSICGNSSSQSSCSYGGLSSSSSLTQSSCVVTQQMASMGSSCSMMQ
QSSVQPAANCSIKSPQSCVVERPPSNQQQQPPPPPPQQPQPPPPQPQPAPQPPPPQQQPQ
QQPQPQPQQPPPPPPPQQQPPLSQCSMNNSFTPAPMIMEIPESGSTGNISIYERIPGDFG
AGSYSQPSATFSLAKLQQLTNTIMDPHAMPYSHSPAVTSYATSVSLSNTGLAQLAPSHPL
AGTPQAQATMTPPPNLASTTMNLTSPLLQCNMSATNIGIPHTQRLQGQMPVKGHISIRSK
SAPLPSAAAHQQQLYGRSPSAVAMQAGPRALAVQRGMNMGVNLMPTPAYNVNSMNMNTLN
AMNSYRMTQPMMNSSYHSNPAYMNQTAQYPMQMQMGMMGSQAYTQQPMQPNPHGNMMYTG
PSHHSYMNAAGVPKQSLNGPYMRR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>